Microvascular dysfunction, myocardial ischemia, and progression to heart failure in patients with hypertrophic cardiomyopathy

Journal of Cardiovascular Translational Research

Volumn 2, Issue 4, 2009, Pages 452-461

  Cecchi, Franco ^a   Sgalambro, Aurelio ^a   Baldi, Massimo ^a   Sotgia, Barbara ^a   Antoniucci, Davide ^a   Camici, Paolo G ^b   Sciagrà, Roberto ^a   Olivotto, Iacopo ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Hypertrophic Cardiomyopathy; Microvascular Dysfunction; Myocardial Ischemia; Outcome; Positron Emission Tomography

Indexed keywords

ANGIOCARDIOGRAPHY; CASE MANAGEMENT; CLINICAL FEATURE; DETERIORATION; ELECTROCARDIOGRAM; EXERCISE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; HOLTER MONITORING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MICROANGIOPATHY; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SINUS TACHYCARDIA; STRESS ECHOCARDIOGRAPHY; ARRHYTHMIAS, CARDIAC; COMPLICATION; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; DISEASE COURSE; MICROCIRCULATION; MICROVASCULATURE; MYOCARDIAL ISCHEMIA; VENTRICULAR OUTFLOW OBSTRUCTION;

ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHY, HYPERTROPHIC; CORONARY CIRCULATION; CORONARY VESSELS; DISEASE PROGRESSION; EXERCISE; HEART FAILURE; HUMANS; MICROCIRCULATION; MICROVESSELS; MYOCARDIAL ISCHEMIA; RISK FACTORS; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 75949095471     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-009-9142-5     Document Type: Review

References (48)

1. AS Adabag BJ Maron E Appelbaum CJ Harrigan JL Buros CM Gibson, et al. 2008 Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance Journal of the American College of Cardiology 51 1369 1374 10.1016/j.jacc.2007.11.071 18387438
2. F Bartoloni Saint Omer F Gori F Marchi P Pagnini 1976 Infarto miocardico acuto settale in bambino di otto anni con miocardiopatia ipertrofica ostruttiva Archivio "De Vecchi" LXI 41 54
3. C Basso G Thiene D Corrado, et al. 2000 Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia Human Pathology 31 988 998 10.1053/hupa.2000.16659 1:STN:280:DC%2BD3cvlvVWltQ%3D%3D 10987261 (Pubitemid 30672621)
4. PG Camici G Chiriatti R Lorenzoni, et al. 1991 Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: A study with nitrogen-13 ammonia and positron emission tomography Journal of the American College of Cardiology 17 879 886 1:STN:280:DyaK3M7lsVGqtQ%3D%3D 1999624
5. RO Cannon V Dilsizian PT O'Gara, et al. 1991 Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy Circulation 83 1660 1667 2022023
6. RO Cannon CL McIntosh WH Schenke, et al. 1989 Effect of surgical reduction of left ventricular outflow tract obstruction on hemodynamics, coronary flow and myocardial metabolism in hypertrophic cardiomyopathy Circulation 79 766 775 2924410
7. F Cecchi I Olivotto S Betocchi, et al. 2005 The Italian Registry for hypertrophic cardiomyopathy: A nationwide survey American Heart Journal 150 5 947 954 10.1016/j.ahj.2005.01.005 16290970 (Pubitemid 41607773)
8. F Cecchi I Olivotto R Gistri, et al. 2003 Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy New England Journal of Medicine 349 1027 1035 10.1056/NEJMoa025050 1:CAS:528:DC%2BD3sXntlagtbc%3D 12968086 (Pubitemid 37087617)
9. F Cecchi I Olivotto A Montereggi, et al. 1995 Hypertrophic cardiomyopathy in Tuscany: Clinical course and outcome in an unselected regional population Journal of the American College of Cardiology 26 1529 1536 10.1016/0735-1097(95) 00353-3 1:STN:280:DyaK28%2FmtV2msg%3D%3D 7594081
10. F Cecchi I Olivotto S Nistri D Antoniucci MH Yacoub 2006 Midventricular obstruction and clinical decision-making in obstructive hypertrophic cardiomyopathy Herz 31 9 871 876 10.1007/s00059-006-2928-1 17180650 (Pubitemid 46028460)
11. E Coakley DH Steinberg A Tibrewala F Asch AD Pichard KM Kent, et al. 2008 Effect of alcohol septal ablation in patients with hypertrophic cardiomyopathy on the electrocardiographic pattern American Journal of Cardiology 102 5 621 624 10.1016/j.amjcard.2008.04.043 18721524
12. 18F-FDG uptake as a surrogate marker for antecedent ischemia Journal of Nuclear Medicine 49 12 1909 1911 10.2967/jnumed.108.053892 18997055
13. 18F-FDG uptake after exercise-induced myocardial ischemia in patients with coronary artery disease Journal of Nuclear Medicine 49 12 1986 1991 10.2967/jnumed.108. 052936 18997035
14. PM Elliott JC Kaski K Prasad H Seo, et al. 1996 Chest pain during daily life in patients with hypertrophic cardiomyopathy: An ambulatory electrocardiographic study European Heart Journal 17 1056 1064 1:STN:280:DyaK28vgsFertg%3D%3D 8809524
15. D Erdogan H Gullu M Caliskan, et al. 2007 Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy Heart 93 319 324 10.1136/hrt.2006.091751 1:CAS:528:DC%2BD2sXjvFSjsb8%3D 17065184 (Pubitemid 46579520)
16. S Fighali Z Krajcer S Edelman, et al. 1987 Progression of hypertrophic cardiomyopathy into a hypokinetic left ventricle: Higher incidence in patients with midventricular obstruction Journal of the American College of Radiology 9 2 288 294 1:STN:280:DyaL2s7htValtQ%3D%3D
17. R Gistri F Cecchi L Choudhury A Montereggi O Sorace PA Salvadori, et al. 1994 Effect of verapamil on absolute myocardial blood flow in hypertrophic cardiomyopathy American Journal of Cardiology 74 363 368 10.1016/0002-9149(94) 90404-9 1:STN:280:DyaK2czjslKqtA%3D%3D 8059699 (Pubitemid 24253474)
18. KM Harris P Spirito MS Maron, et al. 2006 Prevalence, clinical profile and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy Circulation 114 216 225 10.1161/CIRCULATIONAHA.105. 583500 16831987 (Pubitemid 44297115)
19. B Johansson S Mörner A Waldenström P Stål 2008 Myocardial capillary supply is limited in hypertrophic cardiomyopathy: A morphological analysis International Journal of Cardiology 126 2 252 257 10.1016/j.ijcard. 2007.04.003 17532066 (Pubitemid 351602107)
20. MJ Kofflard M Michels R Krams M Kliffen ML Geleijnse FJ Ten Cate, et al. 2007 Coronary flow reserve in hypertrophic cardiomyopathy: Relation with microvascular dysfunction and pathophysiological characteristics Netherlands Heart Journal 15 6 209 215 1:STN:280:DC%2BD2szpsFWqtQ%3D%3D 17612685
21. R Krams MJ Kofflard DJ Duncker C Von Birgelen S Carlier M Kliffen, et al. 1998 Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation Circulation 97 3 230 233 1:STN:280:DyaK1c7it1emsQ%3D%3D 9462521
22. E Lazzeroni E Picano L Morozzi AR Maurizio G Palma R Ceriati, et al. 1997 Dipyridamole-induced ischemia as a prognostic marker of future adverse cardiac events in adult patients with hypertrophic cardiomyopathy. Echo Persantine Italian Cooperative (EPIC) Study Group, Subproject Hypertrophic Cardiomyopathy Circulation 96 4268 4272 1:STN:280:DyaK1c%2Fnslektg%3D%3D 9416892
23. R Lorenzoni R Gistri F Cecchi I Olivotto G Chiriatti P Elliott, et al. 1997 Syncope and ventricular arrhythmias in hypertrophic cardiomyopathy are not related to the derangement of coronary microvascular function European Heart Journal 18 1946 1950 1:STN:280:DyaK1c7gvVGrsQ%3D%3D 9447323
24. MA Losi S Betocchi M Aversa R Lombardi M Miranda A Cacace, et al. 2003 Dobutamine stress echocardiography in hypertrophic cardiomyopathy Cardiology 100 93 100 10.1159/000073045 14557696 (Pubitemid 37266930)
25. BJ Maron 2002 Hypertrophic cardiomyopathy: A systematic review JAMA 287 1308 1320 10.1001/jama.287.10.1308 11886323
26. BJ Maron SE Epstein WC Roberts 1979 Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries American Journal of Cardiology 43 1086 1102 10.1016/0002-9149(79)90139-5 1:STN:280:DyaE1M7osV2jug%3D%3D 571670 (Pubitemid 9190990)
27. BJ Maron WJ McKenna GK Danielson LJ Kappenberger HJ Kuhn CE Seidman, et al. 2003 American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines European Heart Journal 24 21 1965 1991 10.1016/S0195- 668X(03)00479-2 14585256 (Pubitemid 37336422)
28. MS Maron I Olivotto S Betocchi, et al. 2003 Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy New England Journal of Medicine 348 295 303 10.1056/NEJMoa021332 12540642 (Pubitemid 36119984)
29. MS Maron I Olivotto BJ Maron SK Prasad F Cecchi JE Udelson, et al. 2009 The case for myocardial ischemia in hypertrophic cardiomyopathy Journal of the American College of Cardiology 54 9 866 875 10.1016/j.jacc.2009.04.072 19695469
30. BJ Maron I Olivotto P Spirito, et al. 2000 Epidemiology of hypertrophic cardiomyopathy-related death: Revisited in a large non-referral-based patient population Circulation 102 858 864 1:STN:280:DC%2BD3cvhvFWhuw%3D%3D 10952953
31. MS Maron I Olivotto AG Zenovich MS Link NG Pandian JT Kuvin, et al. 2006 Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction Circulation 114 2232 2239 10.1161/CIRCULATIONAHA.106. 644682 17088454 (Pubitemid 44789498)
32. BJ Maron P Spirito 1998 Implications of left ventricular remodeling in hypertrophic cardiomyopathy American Journal of Cardiology 81 1339 1344 10.1016/S0002-9149(98)00164-7 1:STN:280:DyaK1c3ptlOgsQ%3D%3D 9631972 (Pubitemid 28268673)
33. BJ Maron JK Wolfson SE Epstein, et al. 1986 Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy Journal of the American College of Cardiology 8 545 557 1:STN:280:DyaL28zgsFChtA%3D%3D 3745699
34. N Miyai T Kawasaki T Taniguchi T Kamitani S Kawasaki H Sugihara 2005 Exercise-induced ST-segment depression and myocardial ischemia in patients with hypertrophic cardiomyopathy: Myocardial scintigraphic study Journal of Cardiology 46 4 141 147 16252566
35. JC Moon WJ McKenna JA McCrohon PM Elliott GC Smith DJ Pennell 2003 Toward clinic risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance Journal of the American College of Cardiology 41 1561 1567 10.1016/S0735-1097(03)00189-X 12742298 (Pubitemid 36543376)
36. JJ Mourad O Hanon JR Deverre, et al. 2003 Improvement of impaired coronary vasodilator reserve in hypertensive patients by low-dose ACE inhibitor/diuretic therapy: A pilot PET study Journal of the Renin-Angiotensin-Aldosterone System 4 94 95 1:CAS:528:DC%2BD3sXlsFWqtbc%3D 12806590
37. LA Nikolaidis A Doverspike R Huerbin T Hentosz RP Shannon 2002 Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism Circulation 105 2785 2790 10.1161/01.CIR.0000017433.90061.2E 1:CAS:528:DC%2BD38Xlt1yku78%3D 12057995 (Pubitemid 34615152)
38. I Olivotto F Cecchi SA Casey A Dolara JH Traverse BJ Maron 2001 Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy Circulation 104 2517 2524 10.1161/hc4601.097997 1:STN:280:DC%2BD3MnmvVOlsA%3D%3D 11714644
39. I Olivotto F Cecchi R Gistri R Lorenzoni G Chiriatti D Vargiu, et al. 2006 Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy Journal of the American College of Cardiology 47 1043 1048 10.1016/j.jacc.2005.10.050 16516091 (Pubitemid 43312768)
40. SR Ommen BJ Maron I Olivotto, et al. 2005 Long-term effects of surgical septal myectomy on survival of patients with obstructive hypertrophic cardiomyopathy Journal of the American College of Cardiology 46 470 476 10.1016/j.jacc.2005.02.090 16053960 (Pubitemid 41040288)
41. O Parodi D Neglia C Palombo G Sambuceti A Giorgetti C Marabotti, et al. 1997 Comparative effects of enalapril and verapamil on myocardial blood flow in systemic hypertension Circulation 96 864 873 1:CAS:528:DyaK2sXls1ektbs%3D 9264494
42. A Pasternac J Noble Y Streulens, et al. 1982 Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries Circulation 62 778 789
43. SE Petersen M Jerosch-Herold LE Hudsmith MD Robson JM Francis HA Doll, et al. 2007 Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: New insights from multiparametric magnetic resonance imaging Circulation 115 2418 2425 10.1161/CIRCULATIONAHA.106.657023 17452610 (Pubitemid 46717964)
44. DR Rosing U Idanpaan-Heikkila BJ Maron RO Bonow SE Epstein 1985 Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy American Journal of Cardiology 55 185B 195B 10.1016/0002-9149(85)90630-7 1:STN:280: DyaL2M7hvV2rtQ%3D%3D 3881913
45. R Sciagrà B Sotgia I Olivotto F Cecchi, et al. 2009 Relationship between atrial fibrillation and blunted hyperemic myocardial blood flow in patients with hypertrophic cardiomyopathy Journal of Nuclear Cardiology 16 92 96 10.1007/s12350-008-9005-5 19152133
46. B Sotgia R Sciagrà I Olivotto G Casolo L Rega I Betti, et al. 2008 Spatial relationship between coronary microvascular dysfunction and delayed contrast enhancement in patients with hypertrophic cardiomyopathy Journal of Nuclear Medicine 49 1090 1096 10.2967/jnumed.107.050138 18552138
47. WJ Stafford RG Trohman M Bilsker, et al. 1986 Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy Journal of the American College of Cardiology 7 701 704 1:STN:280:DyaL287ktFeitA%3D%3D 3950248
48. ED Wigle H Rakowski BP Kimball, et al. 1995 Hypertrophic cardiomyopathy: Clinical spectrum and treatment Circulation 92 1680 1692 1:STN:280: DyaK2MvgtFeiug%3D%3D 7671349